Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Profit After Tax (2020 - 2026)

Nuvalent's (NUVL) quarterly Profit After Tax came in at -$113.0 million in Q1 2026, down 33.58% YoY from -$170.1 million in Q1 2025, and up 6.74% on a QoQ basis from -$121.2 million in Q4 2025.

Analysis

Nuvalent (NUVL) Profit After Tax (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Profit After Tax data on file, last reported at -$113.0 million in Q1 2026.

  • Quarterly Profit After Tax fell 33.58% year-over-year to -$113.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$455.2 million (down 50.64% YoY) and the FY2025 annual result came in at -$425.4 million, down 63.14% from the prior year.
  • Profit After Tax rose to -$113.0 million in Q1 2026, from -$121.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$17.5 million in Q1 2022 to a low of -$121.4 million in Q3 2025.
  • A 5-year average of -$59.4 million and a median of -$44.5 million in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2022 — Profit After Tax slumped 158.64% — and 2026, when it tumbled 33.58%.
  • Tracing NUVL's Profit After Tax over 5 years: stood at -$26.1 million in 2022, then plunged by 46.58% to -$38.3 million in 2023, then tumbled by 98.75% to -$76.1 million in 2024, then slumped by 59.2% to -$121.2 million in 2025, then climbed by 6.74% to -$113.0 million in 2026.
  • The last three Profit After Tax figures came in at -$113.0 million (Q1 2026), -$121.2 million (Q4 2025), and -$121.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - -112.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -112.99 Mn
Dec 31, 2025 -118.70 Mn
Sep 30, 2025 -122.44 Mn
Jun 30, 2025 -99.65 Mn
Mar 31, 2025 -84.58 Mn
Dec 31, 2024 -74.85 Mn
Sep 30, 2024 -84.35 Mn
Jun 30, 2024 -57.17 Mn
Mar 31, 2024 -44.48 Mn
Dec 31, 2023 -37.48 Mn
Sep 30, 2023 -33.65 Mn
Jun 30, 2023 -29.09 Mn
Mar 31, 2023 -25.19 Mn
Dec 31, 2022 -25.75 Mn
Sep 30, 2022 -19.72 Mn
Jun 30, 2022 -18.47 Mn
Mar 31, 2022 -17.55 Mn
Dec 31, 2021 -17.49 Mn
Sep 30, 2021 -12.45 Mn
Jun 30, 2021 -9.84 Mn